Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Julia Rey

2PUBLICATIONS

26CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Apr 20, 2026

Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial.

|Feb 25, 2025

Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study.

Peter A Fasching, Sabine Schmatloch, Jan Hauke

Pageof 1

Frequent Collaborators

2 joint publications

Jens-Uwe Blohmer

2 joint publications

Michael Untch

2 joint publications

Sibylle Loibl

2 joint publications

Jens Huober

2 joint publications

Andreas Hartkopf

2 joint publications

Carsten Denkert

2 joint publications

Andreas Schneeweiss

1 joint publications

Sabine Schmatloch

1 joint publications

Michael Braun

1 joint publications

Peter Klare

Frequent Collaborators

2 joint publications

Jens-Uwe Blohmer

2 joint publications

Michael Untch

2 joint publications

Sibylle Loibl

2 joint publications

Jens Huober

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

See more related videos